- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.60 Å
- Oligo State
- homo-24-mer
- Ligands
- 24 x 4LF: N-[2-[2,5-bis(oxidanylidene)pyrrol-1-yl]ethyl]-2,3-bis(oxidanyl)benzamide(Covalent)
- 24 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 2 residues within 4Å:- Chain A: Q.6, N.7
Ligand excluded by PLIPSO4.10: 2 residues within 4Å:- Chain B: Q.6, N.7
Ligand excluded by PLIPSO4.18: 2 residues within 4Å:- Chain C: Q.6, N.7
Ligand excluded by PLIPSO4.26: 2 residues within 4Å:- Chain D: Q.6, N.7
Ligand excluded by PLIPSO4.34: 2 residues within 4Å:- Chain E: Q.6, N.7
Ligand excluded by PLIPSO4.42: 2 residues within 4Å:- Chain F: Q.6, N.7
Ligand excluded by PLIPSO4.50: 2 residues within 4Å:- Chain G: Q.6, N.7
Ligand excluded by PLIPSO4.58: 2 residues within 4Å:- Chain H: Q.6, N.7
Ligand excluded by PLIPSO4.66: 2 residues within 4Å:- Chain I: Q.6, N.7
Ligand excluded by PLIPSO4.74: 2 residues within 4Å:- Chain J: Q.6, N.7
Ligand excluded by PLIPSO4.82: 2 residues within 4Å:- Chain K: Q.6, N.7
Ligand excluded by PLIPSO4.90: 2 residues within 4Å:- Chain L: Q.6, N.7
Ligand excluded by PLIPSO4.98: 2 residues within 4Å:- Chain M: Q.6, N.7
Ligand excluded by PLIPSO4.106: 2 residues within 4Å:- Chain N: Q.6, N.7
Ligand excluded by PLIPSO4.114: 2 residues within 4Å:- Chain O: Q.6, N.7
Ligand excluded by PLIPSO4.122: 2 residues within 4Å:- Chain P: Q.6, N.7
Ligand excluded by PLIPSO4.130: 2 residues within 4Å:- Chain Q: Q.6, N.7
Ligand excluded by PLIPSO4.138: 2 residues within 4Å:- Chain R: Q.6, N.7
Ligand excluded by PLIPSO4.146: 2 residues within 4Å:- Chain S: Q.6, N.7
Ligand excluded by PLIPSO4.154: 2 residues within 4Å:- Chain T: Q.6, N.7
Ligand excluded by PLIPSO4.162: 2 residues within 4Å:- Chain U: Q.6, N.7
Ligand excluded by PLIPSO4.170: 2 residues within 4Å:- Chain V: Q.6, N.7
Ligand excluded by PLIPSO4.178: 2 residues within 4Å:- Chain W: Q.6, N.7
Ligand excluded by PLIPSO4.186: 2 residues within 4Å:- Chain X: Q.6, N.7
Ligand excluded by PLIP- 96 x CD: CADMIUM ION(Non-covalent)
CD.3: 2 residues within 4Å:- Chain A: D.80
- Chain V: Q.82
Ligand excluded by PLIPCD.4: 8 residues within 4Å:- Chain A: S.131
- Chain E: S.131
- Chain I: S.131
- Ligands: CD.6, CD.36, CD.38, CD.68, CD.70
Ligand excluded by PLIPCD.5: 5 residues within 4Å:- Chain A: E.130
- Chain E: E.130
- Chain I: E.130
- Ligands: CD.37, CD.69
Ligand excluded by PLIPCD.6: 11 residues within 4Å:- Chain A: D.127, S.131
- Chain E: D.127, S.131
- Chain I: D.127, S.131
- Ligands: CD.4, CD.36, CD.38, CD.68, CD.70
Ligand excluded by PLIPCD.11: 2 residues within 4Å:- Chain B: D.80
- Chain W: Q.82
Ligand excluded by PLIPCD.12: 8 residues within 4Å:- Chain B: S.131
- Chain G: S.131
- Chain L: S.131
- Ligands: CD.14, CD.52, CD.54, CD.92, CD.94
Ligand excluded by PLIPCD.13: 5 residues within 4Å:- Chain B: E.130
- Chain G: E.130
- Chain L: E.130
- Ligands: CD.53, CD.93
Ligand excluded by PLIPCD.14: 11 residues within 4Å:- Chain B: D.127, S.131
- Chain G: D.127, S.131
- Chain L: D.127, S.131
- Ligands: CD.12, CD.52, CD.54, CD.92, CD.94
Ligand excluded by PLIPCD.19: 2 residues within 4Å:- Chain C: D.80
- Chain X: Q.82
Ligand excluded by PLIPCD.20: 8 residues within 4Å:- Chain C: S.131
- Chain H: S.131
- Chain J: S.131
- Ligands: CD.22, CD.60, CD.62, CD.76, CD.78
Ligand excluded by PLIPCD.21: 5 residues within 4Å:- Chain C: E.130
- Chain H: E.130
- Chain J: E.130
- Ligands: CD.61, CD.77
Ligand excluded by PLIPCD.22: 11 residues within 4Å:- Chain C: D.127, S.131
- Chain H: D.127, S.131
- Chain J: D.127, S.131
- Ligands: CD.20, CD.60, CD.62, CD.76, CD.78
Ligand excluded by PLIPCD.27: 2 residues within 4Å:- Chain D: D.80
- Chain U: Q.82
Ligand excluded by PLIPCD.28: 8 residues within 4Å:- Chain D: S.131
- Chain F: S.131
- Chain K: S.131
- Ligands: CD.30, CD.44, CD.46, CD.84, CD.86
Ligand excluded by PLIPCD.29: 5 residues within 4Å:- Chain D: E.130
- Chain F: E.130
- Chain K: E.130
- Ligands: CD.45, CD.85
Ligand excluded by PLIPCD.30: 11 residues within 4Å:- Chain D: D.127, S.131
- Chain F: D.127, S.131
- Chain K: D.127, S.131
- Ligands: CD.28, CD.44, CD.46, CD.84, CD.86
Ligand excluded by PLIPCD.35: 2 residues within 4Å:- Chain E: D.80
- Chain Q: Q.82
Ligand excluded by PLIPCD.36: 8 residues within 4Å:- Chain A: S.131
- Chain E: S.131
- Chain I: S.131
- Ligands: CD.4, CD.6, CD.38, CD.68, CD.70
Ligand excluded by PLIPCD.37: 5 residues within 4Å:- Chain A: E.130
- Chain E: E.130
- Chain I: E.130
- Ligands: CD.5, CD.69
Ligand excluded by PLIPCD.38: 11 residues within 4Å:- Chain A: D.127, S.131
- Chain E: D.127, S.131
- Chain I: D.127, S.131
- Ligands: CD.4, CD.6, CD.36, CD.68, CD.70
Ligand excluded by PLIPCD.43: 2 residues within 4Å:- Chain F: D.80
- Chain T: Q.82
Ligand excluded by PLIPCD.44: 8 residues within 4Å:- Chain D: S.131
- Chain F: S.131
- Chain K: S.131
- Ligands: CD.28, CD.30, CD.46, CD.84, CD.86
Ligand excluded by PLIPCD.45: 5 residues within 4Å:- Chain D: E.130
- Chain F: E.130
- Chain K: E.130
- Ligands: CD.29, CD.85
Ligand excluded by PLIPCD.46: 11 residues within 4Å:- Chain D: D.127, S.131
- Chain F: D.127, S.131
- Chain K: D.127, S.131
- Ligands: CD.28, CD.30, CD.44, CD.84, CD.86
Ligand excluded by PLIPCD.51: 2 residues within 4Å:- Chain G: D.80
- Chain S: Q.82
Ligand excluded by PLIPCD.52: 8 residues within 4Å:- Chain B: S.131
- Chain G: S.131
- Chain L: S.131
- Ligands: CD.12, CD.14, CD.54, CD.92, CD.94
Ligand excluded by PLIPCD.53: 5 residues within 4Å:- Chain B: E.130
- Chain G: E.130
- Chain L: E.130
- Ligands: CD.13, CD.93
Ligand excluded by PLIPCD.54: 11 residues within 4Å:- Chain B: D.127, S.131
- Chain G: D.127, S.131
- Chain L: D.127, S.131
- Ligands: CD.12, CD.14, CD.52, CD.92, CD.94
Ligand excluded by PLIPCD.59: 2 residues within 4Å:- Chain H: D.80
- Chain R: Q.82
Ligand excluded by PLIPCD.60: 8 residues within 4Å:- Chain C: S.131
- Chain H: S.131
- Chain J: S.131
- Ligands: CD.20, CD.22, CD.62, CD.76, CD.78
Ligand excluded by PLIPCD.61: 5 residues within 4Å:- Chain C: E.130
- Chain H: E.130
- Chain J: E.130
- Ligands: CD.21, CD.77
Ligand excluded by PLIPCD.62: 11 residues within 4Å:- Chain C: D.127, S.131
- Chain H: D.127, S.131
- Chain J: D.127, S.131
- Ligands: CD.20, CD.22, CD.60, CD.76, CD.78
Ligand excluded by PLIPCD.67: 2 residues within 4Å:- Chain I: D.80
- Chain P: Q.82
Ligand excluded by PLIPCD.68: 8 residues within 4Å:- Chain A: S.131
- Chain E: S.131
- Chain I: S.131
- Ligands: CD.4, CD.6, CD.36, CD.38, CD.70
Ligand excluded by PLIPCD.69: 5 residues within 4Å:- Chain A: E.130
- Chain E: E.130
- Chain I: E.130
- Ligands: CD.5, CD.37
Ligand excluded by PLIPCD.70: 11 residues within 4Å:- Chain A: D.127, S.131
- Chain E: D.127, S.131
- Chain I: D.127, S.131
- Ligands: CD.4, CD.6, CD.36, CD.38, CD.68
Ligand excluded by PLIPCD.75: 2 residues within 4Å:- Chain J: D.80
- Chain M: Q.82
Ligand excluded by PLIPCD.76: 8 residues within 4Å:- Chain C: S.131
- Chain H: S.131
- Chain J: S.131
- Ligands: CD.20, CD.22, CD.60, CD.62, CD.78
Ligand excluded by PLIPCD.77: 5 residues within 4Å:- Chain C: E.130
- Chain H: E.130
- Chain J: E.130
- Ligands: CD.21, CD.61
Ligand excluded by PLIPCD.78: 11 residues within 4Å:- Chain C: D.127, S.131
- Chain H: D.127, S.131
- Chain J: D.127, S.131
- Ligands: CD.20, CD.22, CD.60, CD.62, CD.76
Ligand excluded by PLIPCD.83: 2 residues within 4Å:- Chain K: D.80
- Chain N: Q.82
Ligand excluded by PLIPCD.84: 8 residues within 4Å:- Chain D: S.131
- Chain F: S.131
- Chain K: S.131
- Ligands: CD.28, CD.30, CD.44, CD.46, CD.86
Ligand excluded by PLIPCD.85: 5 residues within 4Å:- Chain D: E.130
- Chain F: E.130
- Chain K: E.130
- Ligands: CD.29, CD.45
Ligand excluded by PLIPCD.86: 11 residues within 4Å:- Chain D: D.127, S.131
- Chain F: D.127, S.131
- Chain K: D.127, S.131
- Ligands: CD.28, CD.30, CD.44, CD.46, CD.84
Ligand excluded by PLIPCD.91: 2 residues within 4Å:- Chain L: D.80
- Chain O: Q.82
Ligand excluded by PLIPCD.92: 8 residues within 4Å:- Chain B: S.131
- Chain G: S.131
- Chain L: S.131
- Ligands: CD.12, CD.14, CD.52, CD.54, CD.94
Ligand excluded by PLIPCD.93: 5 residues within 4Å:- Chain B: E.130
- Chain G: E.130
- Chain L: E.130
- Ligands: CD.13, CD.53
Ligand excluded by PLIPCD.94: 11 residues within 4Å:- Chain B: D.127, S.131
- Chain G: D.127, S.131
- Chain L: D.127, S.131
- Ligands: CD.12, CD.14, CD.52, CD.54, CD.92
Ligand excluded by PLIPCD.99: 2 residues within 4Å:- Chain J: Q.82
- Chain M: D.80
Ligand excluded by PLIPCD.100: 8 residues within 4Å:- Chain M: S.131
- Chain Q: S.131
- Chain U: S.131
- Ligands: CD.102, CD.132, CD.134, CD.164, CD.166
Ligand excluded by PLIPCD.101: 5 residues within 4Å:- Chain M: E.130
- Chain Q: E.130
- Chain U: E.130
- Ligands: CD.133, CD.165
Ligand excluded by PLIPCD.102: 11 residues within 4Å:- Chain M: D.127, S.131
- Chain Q: D.127, S.131
- Chain U: D.127, S.131
- Ligands: CD.100, CD.132, CD.134, CD.164, CD.166
Ligand excluded by PLIPCD.107: 2 residues within 4Å:- Chain K: Q.82
- Chain N: D.80
Ligand excluded by PLIPCD.108: 8 residues within 4Å:- Chain N: S.131
- Chain S: S.131
- Chain X: S.131
- Ligands: CD.110, CD.148, CD.150, CD.188, CD.190
Ligand excluded by PLIPCD.109: 5 residues within 4Å:- Chain N: E.130
- Chain S: E.130
- Chain X: E.130
- Ligands: CD.149, CD.189
Ligand excluded by PLIPCD.110: 11 residues within 4Å:- Chain N: D.127, S.131
- Chain S: D.127, S.131
- Chain X: D.127, S.131
- Ligands: CD.108, CD.148, CD.150, CD.188, CD.190
Ligand excluded by PLIPCD.115: 2 residues within 4Å:- Chain L: Q.82
- Chain O: D.80
Ligand excluded by PLIPCD.116: 8 residues within 4Å:- Chain O: S.131
- Chain T: S.131
- Chain V: S.131
- Ligands: CD.118, CD.156, CD.158, CD.172, CD.174
Ligand excluded by PLIPCD.117: 5 residues within 4Å:- Chain O: E.130
- Chain T: E.130
- Chain V: E.130
- Ligands: CD.157, CD.173
Ligand excluded by PLIPCD.118: 11 residues within 4Å:- Chain O: D.127, S.131
- Chain T: D.127, S.131
- Chain V: D.127, S.131
- Ligands: CD.116, CD.156, CD.158, CD.172, CD.174
Ligand excluded by PLIPCD.123: 2 residues within 4Å:- Chain I: Q.82
- Chain P: D.80
Ligand excluded by PLIPCD.124: 8 residues within 4Å:- Chain P: S.131
- Chain R: S.131
- Chain W: S.131
- Ligands: CD.126, CD.140, CD.142, CD.180, CD.182
Ligand excluded by PLIPCD.125: 5 residues within 4Å:- Chain P: E.130
- Chain R: E.130
- Chain W: E.130
- Ligands: CD.141, CD.181
Ligand excluded by PLIPCD.126: 11 residues within 4Å:- Chain P: D.127, S.131
- Chain R: D.127, S.131
- Chain W: D.127, S.131
- Ligands: CD.124, CD.140, CD.142, CD.180, CD.182
Ligand excluded by PLIPCD.131: 2 residues within 4Å:- Chain E: Q.82
- Chain Q: D.80
Ligand excluded by PLIPCD.132: 8 residues within 4Å:- Chain M: S.131
- Chain Q: S.131
- Chain U: S.131
- Ligands: CD.100, CD.102, CD.134, CD.164, CD.166
Ligand excluded by PLIPCD.133: 5 residues within 4Å:- Chain M: E.130
- Chain Q: E.130
- Chain U: E.130
- Ligands: CD.101, CD.165
Ligand excluded by PLIPCD.134: 11 residues within 4Å:- Chain M: D.127, S.131
- Chain Q: D.127, S.131
- Chain U: D.127, S.131
- Ligands: CD.100, CD.102, CD.132, CD.164, CD.166
Ligand excluded by PLIPCD.139: 2 residues within 4Å:- Chain H: Q.82
- Chain R: D.80
Ligand excluded by PLIPCD.140: 8 residues within 4Å:- Chain P: S.131
- Chain R: S.131
- Chain W: S.131
- Ligands: CD.124, CD.126, CD.142, CD.180, CD.182
Ligand excluded by PLIPCD.141: 5 residues within 4Å:- Chain P: E.130
- Chain R: E.130
- Chain W: E.130
- Ligands: CD.125, CD.181
Ligand excluded by PLIPCD.142: 11 residues within 4Å:- Chain P: D.127, S.131
- Chain R: D.127, S.131
- Chain W: D.127, S.131
- Ligands: CD.124, CD.126, CD.140, CD.180, CD.182
Ligand excluded by PLIPCD.147: 2 residues within 4Å:- Chain G: Q.82
- Chain S: D.80
Ligand excluded by PLIPCD.148: 8 residues within 4Å:- Chain N: S.131
- Chain S: S.131
- Chain X: S.131
- Ligands: CD.108, CD.110, CD.150, CD.188, CD.190
Ligand excluded by PLIPCD.149: 5 residues within 4Å:- Chain N: E.130
- Chain S: E.130
- Chain X: E.130
- Ligands: CD.109, CD.189
Ligand excluded by PLIPCD.150: 11 residues within 4Å:- Chain N: D.127, S.131
- Chain S: D.127, S.131
- Chain X: D.127, S.131
- Ligands: CD.108, CD.110, CD.148, CD.188, CD.190
Ligand excluded by PLIPCD.155: 2 residues within 4Å:- Chain F: Q.82
- Chain T: D.80
Ligand excluded by PLIPCD.156: 8 residues within 4Å:- Chain O: S.131
- Chain T: S.131
- Chain V: S.131
- Ligands: CD.116, CD.118, CD.158, CD.172, CD.174
Ligand excluded by PLIPCD.157: 5 residues within 4Å:- Chain O: E.130
- Chain T: E.130
- Chain V: E.130
- Ligands: CD.117, CD.173
Ligand excluded by PLIPCD.158: 11 residues within 4Å:- Chain O: D.127, S.131
- Chain T: D.127, S.131
- Chain V: D.127, S.131
- Ligands: CD.116, CD.118, CD.156, CD.172, CD.174
Ligand excluded by PLIPCD.163: 2 residues within 4Å:- Chain D: Q.82
- Chain U: D.80
Ligand excluded by PLIPCD.164: 8 residues within 4Å:- Chain M: S.131
- Chain Q: S.131
- Chain U: S.131
- Ligands: CD.100, CD.102, CD.132, CD.134, CD.166
Ligand excluded by PLIPCD.165: 5 residues within 4Å:- Chain M: E.130
- Chain Q: E.130
- Chain U: E.130
- Ligands: CD.101, CD.133
Ligand excluded by PLIPCD.166: 11 residues within 4Å:- Chain M: D.127, S.131
- Chain Q: D.127, S.131
- Chain U: D.127, S.131
- Ligands: CD.100, CD.102, CD.132, CD.134, CD.164
Ligand excluded by PLIPCD.171: 2 residues within 4Å:- Chain A: Q.82
- Chain V: D.80
Ligand excluded by PLIPCD.172: 8 residues within 4Å:- Chain O: S.131
- Chain T: S.131
- Chain V: S.131
- Ligands: CD.116, CD.118, CD.156, CD.158, CD.174
Ligand excluded by PLIPCD.173: 5 residues within 4Å:- Chain O: E.130
- Chain T: E.130
- Chain V: E.130
- Ligands: CD.117, CD.157
Ligand excluded by PLIPCD.174: 11 residues within 4Å:- Chain O: D.127, S.131
- Chain T: D.127, S.131
- Chain V: D.127, S.131
- Ligands: CD.116, CD.118, CD.156, CD.158, CD.172
Ligand excluded by PLIPCD.179: 2 residues within 4Å:- Chain B: Q.82
- Chain W: D.80
Ligand excluded by PLIPCD.180: 8 residues within 4Å:- Chain P: S.131
- Chain R: S.131
- Chain W: S.131
- Ligands: CD.124, CD.126, CD.140, CD.142, CD.182
Ligand excluded by PLIPCD.181: 5 residues within 4Å:- Chain P: E.130
- Chain R: E.130
- Chain W: E.130
- Ligands: CD.125, CD.141
Ligand excluded by PLIPCD.182: 11 residues within 4Å:- Chain P: D.127, S.131
- Chain R: D.127, S.131
- Chain W: D.127, S.131
- Ligands: CD.124, CD.126, CD.140, CD.142, CD.180
Ligand excluded by PLIPCD.187: 2 residues within 4Å:- Chain C: Q.82
- Chain X: D.80
Ligand excluded by PLIPCD.188: 8 residues within 4Å:- Chain N: S.131
- Chain S: S.131
- Chain X: S.131
- Ligands: CD.108, CD.110, CD.148, CD.150, CD.190
Ligand excluded by PLIPCD.189: 5 residues within 4Å:- Chain N: E.130
- Chain S: E.130
- Chain X: E.130
- Ligands: CD.109, CD.149
Ligand excluded by PLIPCD.190: 11 residues within 4Å:- Chain N: D.127, S.131
- Chain S: D.127, S.131
- Chain X: D.127, S.131
- Ligands: CD.108, CD.110, CD.148, CD.150, CD.188
Ligand excluded by PLIP- 24 x FE: FE (III) ION(Non-functional Binders)
FE.7: 5 residues within 4Å:- Ligands: 4LF.1, 4LF.33, FE.39, 4LF.65, FE.71
No protein-ligand interaction detected (PLIP)FE.15: 5 residues within 4Å:- Ligands: 4LF.9, 4LF.49, FE.55, 4LF.89, FE.95
No protein-ligand interaction detected (PLIP)FE.23: 5 residues within 4Å:- Ligands: 4LF.17, 4LF.57, FE.63, 4LF.73, FE.79
No protein-ligand interaction detected (PLIP)FE.31: 5 residues within 4Å:- Ligands: 4LF.25, 4LF.41, FE.47, 4LF.81, FE.87
No protein-ligand interaction detected (PLIP)FE.39: 5 residues within 4Å:- Ligands: 4LF.1, FE.7, 4LF.33, 4LF.65, FE.71
No protein-ligand interaction detected (PLIP)FE.47: 5 residues within 4Å:- Ligands: 4LF.25, FE.31, 4LF.41, 4LF.81, FE.87
No protein-ligand interaction detected (PLIP)FE.55: 5 residues within 4Å:- Ligands: 4LF.9, FE.15, 4LF.49, 4LF.89, FE.95
No protein-ligand interaction detected (PLIP)FE.63: 5 residues within 4Å:- Ligands: 4LF.17, FE.23, 4LF.57, 4LF.73, FE.79
No protein-ligand interaction detected (PLIP)FE.71: 5 residues within 4Å:- Ligands: 4LF.1, FE.7, 4LF.33, FE.39, 4LF.65
No protein-ligand interaction detected (PLIP)FE.79: 5 residues within 4Å:- Ligands: 4LF.17, FE.23, 4LF.57, FE.63, 4LF.73
No protein-ligand interaction detected (PLIP)FE.87: 5 residues within 4Å:- Ligands: 4LF.25, FE.31, 4LF.41, FE.47, 4LF.81
No protein-ligand interaction detected (PLIP)FE.95: 5 residues within 4Å:- Ligands: 4LF.9, FE.15, 4LF.49, FE.55, 4LF.89
No protein-ligand interaction detected (PLIP)FE.103: 5 residues within 4Å:- Ligands: 4LF.97, 4LF.129, FE.135, 4LF.161, FE.167
No protein-ligand interaction detected (PLIP)FE.111: 5 residues within 4Å:- Ligands: 4LF.105, 4LF.145, FE.151, 4LF.185, FE.191
No protein-ligand interaction detected (PLIP)FE.119: 5 residues within 4Å:- Ligands: 4LF.113, 4LF.153, FE.159, 4LF.169, FE.175
No protein-ligand interaction detected (PLIP)FE.127: 5 residues within 4Å:- Ligands: 4LF.121, 4LF.137, FE.143, 4LF.177, FE.183
No protein-ligand interaction detected (PLIP)FE.135: 5 residues within 4Å:- Ligands: 4LF.97, FE.103, 4LF.129, 4LF.161, FE.167
No protein-ligand interaction detected (PLIP)FE.143: 5 residues within 4Å:- Ligands: 4LF.121, FE.127, 4LF.137, 4LF.177, FE.183
No protein-ligand interaction detected (PLIP)FE.151: 5 residues within 4Å:- Ligands: 4LF.105, FE.111, 4LF.145, 4LF.185, FE.191
No protein-ligand interaction detected (PLIP)FE.159: 5 residues within 4Å:- Ligands: 4LF.113, FE.119, 4LF.153, 4LF.169, FE.175
No protein-ligand interaction detected (PLIP)FE.167: 5 residues within 4Å:- Ligands: 4LF.97, FE.103, 4LF.129, FE.135, 4LF.161
No protein-ligand interaction detected (PLIP)FE.175: 5 residues within 4Å:- Ligands: 4LF.113, FE.119, 4LF.153, FE.159, 4LF.169
No protein-ligand interaction detected (PLIP)FE.183: 5 residues within 4Å:- Ligands: 4LF.121, FE.127, 4LF.137, FE.143, 4LF.177
No protein-ligand interaction detected (PLIP)FE.191: 5 residues within 4Å:- Ligands: 4LF.105, FE.111, 4LF.145, FE.151, 4LF.185
No protein-ligand interaction detected (PLIP)- 24 x GOL: GLYCEROL(Non-functional Binders)
GOL.8: 4 residues within 4Å:- Chain A: K.104, S.105, Q.108
- Chain I: Q.6
Ligand excluded by PLIPGOL.16: 4 residues within 4Å:- Chain B: K.104, S.105, Q.108
- Chain L: Q.6
Ligand excluded by PLIPGOL.24: 4 residues within 4Å:- Chain C: K.104, S.105, Q.108
- Chain J: Q.6
Ligand excluded by PLIPGOL.32: 4 residues within 4Å:- Chain D: K.104, S.105, Q.108
- Chain K: Q.6
Ligand excluded by PLIPGOL.40: 4 residues within 4Å:- Chain A: Q.6
- Chain E: K.104, S.105, Q.108
Ligand excluded by PLIPGOL.48: 4 residues within 4Å:- Chain D: Q.6
- Chain F: K.104, S.105, Q.108
Ligand excluded by PLIPGOL.56: 4 residues within 4Å:- Chain B: Q.6
- Chain G: K.104, S.105, Q.108
Ligand excluded by PLIPGOL.64: 4 residues within 4Å:- Chain C: Q.6
- Chain H: K.104, S.105, Q.108
Ligand excluded by PLIPGOL.72: 4 residues within 4Å:- Chain E: Q.6
- Chain I: K.104, S.105, Q.108
Ligand excluded by PLIPGOL.80: 4 residues within 4Å:- Chain H: Q.6
- Chain J: K.104, S.105, Q.108
Ligand excluded by PLIPGOL.88: 4 residues within 4Å:- Chain F: Q.6
- Chain K: K.104, S.105, Q.108
Ligand excluded by PLIPGOL.96: 4 residues within 4Å:- Chain G: Q.6
- Chain L: K.104, S.105, Q.108
Ligand excluded by PLIPGOL.104: 4 residues within 4Å:- Chain M: K.104, S.105, Q.108
- Chain U: Q.6
Ligand excluded by PLIPGOL.112: 4 residues within 4Å:- Chain N: K.104, S.105, Q.108
- Chain X: Q.6
Ligand excluded by PLIPGOL.120: 4 residues within 4Å:- Chain O: K.104, S.105, Q.108
- Chain V: Q.6
Ligand excluded by PLIPGOL.128: 4 residues within 4Å:- Chain P: K.104, S.105, Q.108
- Chain W: Q.6
Ligand excluded by PLIPGOL.136: 4 residues within 4Å:- Chain M: Q.6
- Chain Q: K.104, S.105, Q.108
Ligand excluded by PLIPGOL.144: 4 residues within 4Å:- Chain P: Q.6
- Chain R: K.104, S.105, Q.108
Ligand excluded by PLIPGOL.152: 4 residues within 4Å:- Chain N: Q.6
- Chain S: K.104, S.105, Q.108
Ligand excluded by PLIPGOL.160: 4 residues within 4Å:- Chain O: Q.6
- Chain T: K.104, S.105, Q.108
Ligand excluded by PLIPGOL.168: 4 residues within 4Å:- Chain Q: Q.6
- Chain U: K.104, S.105, Q.108
Ligand excluded by PLIPGOL.176: 4 residues within 4Å:- Chain T: Q.6
- Chain V: K.104, S.105, Q.108
Ligand excluded by PLIPGOL.184: 4 residues within 4Å:- Chain R: Q.6
- Chain W: K.104, S.105, Q.108
Ligand excluded by PLIPGOL.192: 4 residues within 4Å:- Chain S: Q.6
- Chain X: K.104, S.105, Q.108
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nakajima, H. et al., Construction of an enterobactin analogue with symmetrically arranged monomer subunits of ferritin. Chem.Commun.(Camb.) (2015)
- Release Date
- 2015-11-18
- Peptides
- Ferritin light chain: ABCDEFGHIJKLMNOPQRSTUVWX
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
AI
AJ
AK
AL
AM
AN
AO
AP
AQ
AR
AS
AT
AU
AV
AW
AX
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.60 Å
- Oligo State
- homo-24-mer
- Ligands
- 24 x 4LF: N-[2-[2,5-bis(oxidanylidene)pyrrol-1-yl]ethyl]-2,3-bis(oxidanyl)benzamide(Covalent)
- 24 x SO4: SULFATE ION(Non-functional Binders)
- 96 x CD: CADMIUM ION(Non-covalent)
- 24 x FE: FE (III) ION(Non-functional Binders)
- 24 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nakajima, H. et al., Construction of an enterobactin analogue with symmetrically arranged monomer subunits of ferritin. Chem.Commun.(Camb.) (2015)
- Release Date
- 2015-11-18
- Peptides
- Ferritin light chain: ABCDEFGHIJKLMNOPQRSTUVWX
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
AI
AJ
AK
AL
AM
AN
AO
AP
AQ
AR
AS
AT
AU
AV
AW
AX
A